Cardiovascular
Every post on cardiovascular, newest first.
Posts
Studies5 min read
Three 2026 studies tie Follistatin 344 to artery and prostate effects
Arteries and prostate cells took center stage in three 2026 studies. Follistatin 344 reduced artery plaque in one mouse model and improved blood vessel function in hypertensive rats, but a separate study linked follistatin to prostate cancer resistance.
Studies5 min read
Orforglipron 36 mg lowered weight and blood sugar more than 12 mg
A pooled analysis of six trials found that 36 mg of orforglipron produced larger reductions in weight, waist size, and blood sugar than 12 mg, with similar gastrointestinal side effects. A separate Japanese study reported mostly mild side effects over one year.
Compound pages
The evergreen research summaries these posts build on.
Follistatin 344A myostatin-neutralizing research protein studied for muscle growth.MK-677An oral ghrelin-receptor agonist that amplifies the body's pulsatile growth hormone release.BPC-157Gastric-derived peptide studied for tissue repair and cytoprotection.IGF-1 LR3A long-acting IGF-1 analog that mostly escapes binding-protein control.CJC-1295A long-acting GHRH analog that extends natural growth hormone release for days.OrforglipronOnce-daily oral GLP-1 receptor agonist for weight management.